| Celia L Chan, MD | |
|
1723 Broadway St, Suite 315, Cape Girardeau, MO 63701-4566 | |
| (573) 331-6476 | |
| (573) 331-6526 |
| Full Name | Celia L Chan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1723 Broadway St, Cape Girardeau, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992957039 | NPI | - | NPPES |
| 106745 | Other | MO | MISSOURI LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 106745 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Celia L Chan, MD Po Box 503837, Saint Louis, MO 63150-0001 Ph: (573) 331-6880 | Celia L Chan, MD 1723 Broadway St, Suite 315, Cape Girardeau, MO 63701-4566 Ph: (573) 331-6476 |
News Archive
A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.
Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.
The amino acid homocysteine occurs naturally in the human body, generated as a byproduct of methionine metabolism.
TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
Preventable infectious diseases cause two-thirds of child deaths, according to a new study published today by The Lancet. Experts from the World Health Organization and UNICEF's Child Health Epidemiology Reference Group assessed data from 193 countries to produce estimates by country, region and the world.
› Verified 6 days ago
Kenneth W Retter, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 211 Saint Francis Dr Ste 15, Cape Girardeau, MO 63703 Phone: 573-331-3333 | |
Dr. Aaron Lang, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1723 Broadway St, Suite 315, Cape Girardeau, MO 63701 Phone: 573-332-0226 Fax: 573-332-0344 | |
Philip W Taylor, M.D., FACP Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3250 Gordonville Rd, Ste 301, Cape Girardeau, MO 63703 Phone: 573-334-9641 Fax: 573-331-3120 | |
Tibebe Haile, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Lacey St, Cape Girardeau, MO 63701 Phone: 573-331-6431 Fax: 573-986-5984 | |
Dr. Tiffany Renae Samples, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5770 Fax: 573-331-3974 | |
Narjes F Alamri, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3250 Gordonville Rd Ste 301, Cape Girardeau, MO 63703 Phone: 573-334-9641 Fax: 573-331-4130 | |
Rebecca L Smith, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Suite 15, Cape Girardeau, MO 63703 Phone: 573-331-3333 Fax: 573-331-3334 |